NCT04330040 - Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer | Biotech Hunter

Enrollment

202

Participants

Timeline

Start Date

May 25, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions

Ovarian CancerBreast Cancer

Interventions

DRUG

Olaparib

Tablet

Trial Locations (16)

110005

Research Site, New Delhi

110029

Research Site, Delhi

110063

Research Site, New Delhi

121001

Research Site, Faridabad

160012

Research Site, Chandigarh

380009

Research Site, Ahmedabad

400012

Research Site, Mumbai

400053

Research Site, Mumbai

625107

Research Site, Madurai

632004

Research Site, Vellore

682041

Research Site, Kochi

700099

Research Site, Kolkata

700160

Research Site, Kolkata

751007

Research Site, Bhubaneswar

781023

Research Site, Guwahati

110 085

Research Site, New Delhi